Page last updated: 2024-08-17

quinidine and ly335979

quinidine has been researched along with ly335979 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Baughman, TM; Bell, MG; Cao, J; Dantzig, AH; Ehlhardt, WJ; Elmquist, WF; Gruber, J; Kroin, JS; Law, KL; Norman, BH; Shepard, RL; Shih, C; Starling, JJ; Winter, MA1
Bungay, PM; Elmquist, WF; Sun, H1
Fang, Z; Harder, A; Laplanche, L; Mezler, M; Weinheimer, M; Ye, D1

Other Studies

3 other study(ies) available for quinidine and ly335979

ArticleYear
Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein.
    Advances in enzyme regulation, 1997, Volume: 37

    Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dibenzocycloheptenes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Isoquinolines; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Quinidine; Quinolines; Structure-Activity Relationship; Tetrahydroisoquinolines; Tumor Cells, Cultured; Verapamil

1997
Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:3

    Topics: Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Capillary Permeability; Carrier Proteins; Cross-Over Studies; Dibenzocycloheptenes; Fluoresceins; Fluorescent Dyes; Frontal Lobe; Male; Microdialysis; Models, Biological; Probenecid; Quinidine; Quinolines; Rats; Rats, Wistar; Sensitivity and Specificity; Time Factors

2001
Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
    Pharmaceutical research, 2020, Sep-11, Volume: 37, Issue:10

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Brain Barrier; Brain; Caco-2 Cells; Cell Membrane Permeability; Dibenzocycloheptenes; Diketopiperazines; Dogs; Drug Evaluation, Preclinical; Heterocyclic Compounds, 4 or More Rings; Humans; Madin Darby Canine Kidney Cells; Neoplasm Proteins; Pharmacokinetics; Prazosin; Quinidine; Quinolines; Substrate Specificity; Transfection

2020